MIREN
ZULAICA IJURCO
Investigadora hasta 2022
![Foto de MIREN](/img/nophoto.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (13)
2023
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow-up study
European Journal of Neurology, Vol. 30, Núm. 1, pp. 215-223
2022
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
Senescence plays a role in myotonic dystrophy type 1
JCI insight, Vol. 7, Núm. 19
-
White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study
Scientific reports, Vol. 12, Núm. 1, pp. 3988
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
2020
-
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
The Lancet Neurology, Vol. 19, Núm. 2, pp. 145-156
-
Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain
Genes, Vol. 11, Núm. 5
2019
-
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica, Vol. 138, Núm. 2, pp. 237-250
-
Reply to: “Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion”
Movement Disorders
2018
-
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
The Lancet Neurology, Vol. 17, Núm. 6, pp. 548-558
2016
-
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation
Neurology, Vol. 87, Núm. 12, pp. 1250-1257